We treated CT26 tumor cells with IFN-γ, and TNF-α followed by treatment with CX3CL1 and obtained comparable results wherein CX3CL1 induced robust expression of genes that promote tumor immune-resistance and generate a pro-metastatic niche (Figure 5B). The gene discussed is CX3CL1; the disease is neoplasm.